4.5 Article

Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity

期刊

ARTHRITIS RESEARCH & THERAPY
卷 15, 期 2, 页码 -

出版社

BMC
DOI: 10.1186/ar4199

关键词

-

资金

  1. Spanish Ministry of Science and Innovation [BFU2007-61699, BFU2010-22185]
  2. Marato de TV3 project [080121]
  3. FEDER program from the EU
  4. CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)

向作者/读者索取更多资源

Introduction: Growth arrest-specific gene 6 protein (GAS6) and protein S (ProS) are vitamin K-dependent proteins present in plasma with important regulatory functions in systems of response and repair to damage. They interact with receptor tyrosine kinases of the Tyro3, Axl and MerTK receptor tyrosine kinase (TAM) family, involved in apoptotic cell clearance (efferocytosis) and regulation of the innate immunity. TAM-deficient mice show spontaneous lupus-like symptoms. Here we tested the genetic profile and plasma levels of components of the system in patients with systemic lupus erythematosus (SLE), and compare them with a control healthy population. Methods: Fifty SLE patients and 50 healthy controls with matched age, gender and from the same geographic area were compared. Genetic analysis was performed in GAS6 and the TAM receptor genes on SNPs previously identified. The concentrations of GAS6, total and free ProS, and the soluble forms of the three TAM receptors (sAxl, sMerTK and sTyro3) were measured in plasma from these samples. Results: Plasma concentrations of GAS6 were higher and, total and free ProS were lower in the SLE patients compared to controls, even when patients on oral anticoagulant treatment were discarded. Those parameters correlated with SLE disease activity index (SLEDAI) score, GAS6 being higher in the most severe cases, while free and total ProS were lower. All 3 soluble receptors increased its concentration in plasma of lupus patients. Conclusions: The present study highlights that the GAS6/ProS-TAM system correlates in several ways with disease activity in SLE. We show here that this correlation is affected by common polymorphisms in the genes of the system. These findings underscore the importance of mechanism of regulatory control of innate immunity in the pathology of SLE.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort

G. Pires da Rosa, E. Ferreira, B. Sousa-Pinto, P. Bettencourt, G. Espinosa, R. Cervera

Summary: This study analyzed a cohort of patients with laboratory criteria for anti-phospholipid syndrome (APS) but only presenting "non-criteria" clinical manifestations. The patients were compared with definite APS patients. The results showed that these "clinical non-criteria" patients had mainly hematological and neurological involvements, with significant treatment use. Some patients may progress to future systemic lupus erythematosus (SLE).

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study

Giuseppe Barilaro, Carlo Della Rocca, Alexandra Esteves, Ricard Cervera, Gerard Espinosa

Summary: This study analyzed the association between the average 'adjusted' Global APS Score (aGAPSS) and the change in Damage Index for APS (DIAPS) in patients with thrombotic and non-thrombotic APS. The results showed that a higher average aGAPSS value was associated with an increase in DIAPS during follow-up, suggesting that the average aGAPSS score can predict the increase in DIAPS.

RHEUMATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction

Luis Ortega-Paz, Helena Cristobal, Jose Tomas Ortiz-Perez, Pablo Garcia de Frutos, Guiomar Mendieta, Elena Sandoval, Juan Jose Rodriguez, Emilio Ortega, Ana Garcia-Alvarez, Salvatore Brugaletta, Manel Sabate, Ana Paula Dantas

Summary: In-vitro experiments on myocardial fibroblasts from patients with HFrEF found that Dapagliflozin alone dose-dependently slowed migration of the fibroblasts, and the combination of Dapagliflozin + LCZ696 further reduced migration rate, while Dapagliflozin + spironolactone altered the effects of SGLT2i on biomarkers.

ESC HEART FAILURE (2023)

Editorial Material Medicine, General & Internal

Mortality and causes of death in systemic lupus erythematosus revisited

Giuseppe Barilaro, Ricard Cervera

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Rheumatology

Tocilizumab in Behcet Disease: A Multicenter Study of 30 Patients

Mohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, Alban Deroux, Carlo Salvarani, Giacomo Emmi, Omer Karadag, Gerard Espinosa, Mathilde Leclercq, Gabriele Simonini, Mathieu Vautier, Patrice Cacoub, David Saadoun

Summary: This study evaluated the efficacy of tocilizumab in patients with refractory Behcet disease. The results showed that 83% of patients responded to tocilizumab, with 60% achieving complete response and 23% achieving partial response. Tocilizumab also significantly reduced steroid dosage and the need for concomitant disease-modifying antirheumatic drugs. However, a small number of patients experienced mild to moderate side effects and serious adverse events.

JOURNAL OF RHEUMATOLOGY (2023)

Article Medicine, General & Internal

Heart Valve Involvement in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Study of a Single Centre

Isaac Pons, Joana Louro, Marta Sitges, Barbara Vidal, Ricard Cervera, Gerard Espinosa

Summary: This study describes the prevalence, clinical and laboratory features, and evolution of heart valve involvement in patients with APS. The results showed that 50% of APS patients had valve involvement, with most of them being female and having arterial hypertension and arterial thrombosis. The valve involvement group had a higher mortality rate.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients

Albert Perez-Isidro, Marc Xipell, Arturo Llobell, Noemi De Moner, Gema M. Lledo, Ricard Cervera, Sergio Prieto-Gonzalez, Luis F. Quintana, Gerard Espinosa, Mila Garcia-Ormaechea, Estibaliz Ruiz-Ortiz, Odette Vinas

Summary: This study investigated whether dsDNA antibody-secreting B-cells could be a complementary biomarker for monitoring disease activity and prognosis in SLE patients. The results showed that SLE-ELISpot had the best performance in identifying active patients. High SLE-ELISpot results were associated with haematological involvement and increased risk of disease flare-up, especially renal flare. Combining hypocomplementemia and high SLE-ELISpot results further increased these risks. Therefore, adding SLE-ELISpot to the current follow-up protocol can improve clinicians' personalized care decisions.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Health Care Sciences & Services

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction

Helena Cristobal, Cristina Enjuanes, Montserrat Batlle, Marta Tajes, Begona Campos, Josep Francesch, Pedro Moliner, Marta Farrero, Rut Andrea, Jose Tomas Ortiz-Perez, Albert Morales, Manel Sabate, Josep Comin-Colet, Pablo Garcia de Frutos

Summary: Heart failure (HF) is classified based on left ventricular ejection fraction (EF) into HF with reduced, mildly reduced, and preserved EF. Biomarkers may differ depending on EF type. This study analyzed the levels of soluble form of the AXL receptor tyrosine kinase (sAXL) in HF patients with reduced and preserved EF. The results showed that sAXL levels were a reliable predictor for all-cause and cardiovascular mortality only in the HFpEF cohort.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Dermatology

Pregnancy outcomes in patients exposed to baricitinib in clinical trials and during postmarketing surveillance

Bianca Bergamini, Julien Seneschal, Kristin J. Meyers, Frederick Durand, Ewa Haladyj, Gerard Espinosa, Jacob P. Thyssen

Summary: A total of 117 pregnancies with exposure to baricitinib were analyzed, and the clinical outcomes were found to be comparable to other targeted therapies for immune-mediated diseases or general population.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Editorial Material Rheumatology

Combination of old and new drugs to improve renal outcome in SLE patients

Gerard Espinosa, Ricard Cervera

RHEUMATOLOGY (2023)

Review Medicine, General & Internal

Lysinuric Protein Intolerance and Its Nutritional and Multisystemic Challenges in Pregnancy: A Case Report and Literature Review

Adriana Pane, Camila Milad, Marta Santana-Dominguez, Nuria Banos, Cristina Borras-Novell, Gerard Espinosa, Laura Magnano, Meritxell Nomdedeu, Pedro Juan Moreno-Lozano, Frederic Cofan, Merce Placeres, Rosa Maria Fernandez, Judit Garcia-Villoria, Gloria Garrabou, Irene Vinagre, Laura M. Tanner, Cristina Montserrat-Carbonell, Maria de Tallo Forga-Visa

Summary: Lysinuric protein intolerance (LPI) is a rare metabolic disorder that presents challenges during pregnancy and delivery. This case report highlights the successful natural birth of a woman with LPI, despite various challenges and risks. Collaboration between interdisciplinary teams and careful consideration of risks are crucial in achieving a successful pregnancy and delivery.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Health Care Sciences & Services

Optimizing Noninvasive Vagus Nerve Stimulation for Systemic Lupus Erythematosus: Protocol for a Multicenter Randomized Controlled Trial

Ivan Contreras, Judith Navarro-Otano, Ignasi Rodriguez-Pinto, Amparo Gueemes, Eduarda Alves, Roberto Rios-Garces, Gerard Espinosa, Aida Alejaldre, Aleix Beneyto, Charrise Mary Ramkissoon, Josep Vehi, Ricard Cervera

Summary: This study explores the relationship between the autonomic nervous system and inflammatory pathways in systemic lupus erythematosus patients. The aim is to improve patient outcomes by treating autonomic nervous system dysregulation with noninvasive vagus nerve stimulation. Data on biomarkers, physiological signals, patient outcomes, and quality of life are being collected and analyzed. The results of this study will contribute to the development of patient-tailored vagus nerve stimulation therapies and improve the quality of life for systemic lupus erythematosus patients.

JMIR RESEARCH PROTOCOLS (2023)

暂无数据